Delivery Order SPE2DB20D3303-SPE2DB25FY7U2
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,944.37 firm fixed-price delivery order contract is for the supply of the drug BETASERON 0.3 MG KITS and has a performance period through June 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $36,658.23, is for the delivery of BETASERON 0.3 MG KITS, a pharmaceutical product. The contract has a performance period through August 19, 2024 and utilizes a firm fixed-price pricing arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $46,767.72 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of BETASERON 0.3 MG KITS. The contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no indication of any major subcontractors. This award appears to be part of a larger indefinite delivery contract...
- This federal contract award, valued at $12,990.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covers the procurement of BETASERON 0.3 MG KITS, a specialty pharmaceutical product. The contract has an ultimate completion date of June 25, 2024. There is no set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Betaseron 0.3 mg kits. The $90,870.24 firm fixed-price contract has a completion date of September 24, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for delivering a wide range of medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BETASERON 0.3 MG KITS, a medical supply product, with a ceiling value of $47,814.26 and a completion date of July 10, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $16,226.87 firm-fixed-price delivery order is for the medication Betaseron 0.3 mg kits. The contract has an ultimate completion date of May 1, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly the DLA. The company holds a substantial...
- This is a delivery order award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BETASERON 0.3 MG KITS. The $12,201.41 firm fixed price award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. No set-aside designation was used. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $55,890.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of BETASERON 0.3 MG KITS, a pharmaceutical product, with a completion date of January 4, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00...
- This federal contract award, valued at $5,536.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Betaseron 0.3 mg kits, a specialty medication, to support military and government healthcare programs. The award was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FY7U2Delivery Order
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,326.46, is for the supply of BETASERON 0.3 MG KITS, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award was not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.3k | 1/7/25 |